Product Details for: Egrifta
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Injection
Subcutaneous
1MG
Single-Dose Vial
351(a)
Egrifta
Disc
002
For Injection
Subcutaneous
2MG
Single-Dose Vial
351(a)
Egrifta SV
Rx
003
For Injection
Subcutaneous
11.6MG
Multi-Dose Vial
351(a)
Egrifta WR
Rx
Proper Name
tesamorelin
tesamorelin
BLA Number
022505
022505
Applicant
Theratechnologies Inc.
Theratechnologies Inc.
Original Approval Date
November 10, 2010
November 10, 2010
Date of First Licensure